Vanda Pharmaceuticals (VNDA) Free Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -50.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.19% |
| Dec 31, 2025 | -1,353.42% |
| Sep 30, 2025 | -115.62% |
| Jun 30, 2025 | -121.02% |
| Mar 31, 2025 | -544.10% |
| Dec 31, 2024 | 49.03% |
| Sep 30, 2024 | -610.80% |
| Jun 30, 2024 | 47.00% |
| Mar 31, 2024 | -76.18% |
| Dec 31, 2023 | -143.54% |
| Sep 30, 2023 | -116.34% |
| Jun 30, 2023 | -341.72% |
| Mar 31, 2023 | 699.60% |
| Dec 31, 2022 | -65.43% |
| Sep 30, 2022 | 34.89% |
| Jun 30, 2022 | -70.66% |
| Mar 31, 2022 | -56.18% |
| Dec 31, 2021 | 44.38% |
| Sep 30, 2021 | 3.06% |
| Jun 30, 2021 | -21.34% |
| Mar 31, 2021 | 808.05% |
| Dec 31, 2020 | 88.58% |
| Sep 30, 2020 | 60.03% |
| Jun 30, 2020 | 17.51% |
| Mar 31, 2020 | -113.84% |
| Dec 31, 2019 | -36.20% |
| Sep 30, 2019 | -33.35% |
| Jun 30, 2019 | 369.21% |
| Mar 31, 2019 | 515.44% |
| Dec 31, 2018 | 365.37% |
| Sep 30, 2018 | 376.24% |
| Jun 30, 2018 | 249.65% |
| Mar 31, 2018 | 125.76% |
| Dec 31, 2017 | 274.20% |
| Sep 30, 2017 | 179.91% |
| Jun 30, 2017 | 11.59% |
| Mar 31, 2017 | -19.11% |
| Dec 31, 2016 | -75.70% |
| Sep 30, 2016 | 111.21% |
| Jun 30, 2016 | -127.31% |
| Mar 31, 2016 | -202.66% |
| Dec 31, 2015 | 92.20% |
| Sep 30, 2015 | 25.18% |
| Jun 30, 2015 | 132.36% |
| Mar 31, 2015 | 119.85% |
| Dec 31, 2014 | -12.03% |
| Sep 30, 2014 | 25.55% |
| Jun 30, 2014 | -356.10% |
| Mar 31, 2014 | -162.78% |
| Dec 31, 2013 | 11.59% |
| Sep 30, 2013 | -0.95% |
| Jun 30, 2013 | 34.54% |
| Mar 31, 2013 | 13.17% |
| Dec 31, 2012 | -11.44% |
| Sep 30, 2012 | -41.32% |
| Jun 30, 2012 | -120.00% |
| Mar 31, 2012 | -222.76% |
| Dec 31, 2011 | -144.00% |
| Sep 30, 2011 | -41.98% |